DSIP 5mg Dosage: A Research Guide to Delta Sleep-Inducing Peptide

DSIP 5mg dosage explained: how researchers dilute delta sleep-inducing peptide, typical research ranges, timing, and safety notes before use.

ARTICLE OVERVIEW

DSIP 5mg dosage explained: how researchers dilute delta sleep-inducing peptide, typical research ranges, timing, and safety notes before use.

A 5 mg DSIP vial is a container size, not a dose, and there is no clinically established human dosage for delta sleep-inducing peptide. Research and community write-ups almost always describe DSIP in micrograms, most often somewhere between 100 mcg and 300 mcg per administration, which means one 5 mg vial holds enough peptide for dozens of measured draws. DSIP is not FDA-approved for human use in the United States, so every figure below is a research reference point rather than a medical recommendation.

Why 5 mg Does Not Mean a 5 mg Dose

New users frequently read "5 mg" as the amount to take. It is not. That number describes how much lyophilized powder is sealed inside the vial.

Turning powder into a measurable solution requires reconstitution, which means adding bacteriostatic water or sterile saline so the peptide can be drawn in micrograms. The concentration you create is the number that actually determines your dose.

A 5 mg vial contains 5,000 mcg of peptide. How that 5,000 mcg is divided depends entirely on how much liquid you add.

Reconstitution Math for a 5 mg DSIP Vial

The formula is simple: total peptide in micrograms divided by total volume in milliliters equals concentration in micrograms per milliliter. From there, divide your target dose by the concentration to get the volume to draw.

Bacteriostatic water addedConcentrationVolume for 100 mcgVolume for 250 mcg
1 mL5,000 mcg/mL0.02 mL (2 units on U-100)0.05 mL (5 units)
2 mL2,500 mcg/mL0.04 mL (4 units)0.1 mL (10 units)
3 mL1,667 mcg/mL0.06 mL (6 units)0.15 mL (15 units)
5 mL1,000 mcg/mL0.1 mL (10 units)0.25 mL (25 units)

Lower volumes give a more concentrated solution, which keeps the injected volume small but makes tiny draws harder to measure accurately. Higher volumes are easier to read on a syringe but require injecting more fluid per dose.

Most people working with a 5 mg vial settle on 2 mL or 3 mL of bacteriostatic water as a middle ground. A 2-unit draw on a U-100 syringe is only 0.02 mL, and that margin is easy to misread.

Reported DSIP Dosage Ranges by Route

Route changes both the amount used and the timing. Intranasal and subcutaneous delivery dominate informal reports, while older clinical literature relied on intravenous infusion.

RouteCommonly cited rangeNotes
Subcutaneous100–300 mcg per dayUsually administered in the evening
Intranasal100–500 mcg per day, sometimes splitLower, less predictable absorption
IntravenousWeight-based microgram doses in older studiesLaboratory research only; not self-administered

Someone searching for a dsip nasal spray review is usually trying to work out whether nasal delivery actually works. The honest answer is that absorption through the nasal lining is lower and more variable than subcutaneous injection, so intranasal amounts are often set higher to compensate.

When people look up a dsip peptide injection dosage, they are almost always describing subcutaneous administration with a U-100 insulin syringe. That route gives the most consistent measurement, but it also carries the usual risks of any injection, including irritation and contamination if sterile technique slips.

What a Typical DSIP Dosage Protocol Looks Like

A dsip dosage protocol in community write-ups usually combines three decisions: amount, timing, and cycle length. Most descriptions put administration 30 to 60 minutes before sleep.

  • Amount: start at the low end of the reported range rather than the high end.
  • Timing: evening, close to bedtime.
  • Frequency: daily, or five days on and two days off.
  • Cycle length: commonly two to four weeks, followed by a break and reassessment.
  • Record keeping: log the amount, the time, and how you slept so patterns are visible.

None of these patterns come from large controlled trials of DSIP in humans. They are repeated conventions, not validated schedules, and individual responses to any sleep-active compound vary widely.

DSIP is not FDA-approved for human use in the United States, and it cannot be legally prescribed by a US clinician. Vials sold online carry "for research purposes only" labels, and product quality varies considerably between vendors.

After reconstitution, DSIP is generally stored refrigerated at 2 to 8 degrees Celsius, protected from light, and handled without repeated freeze-thaw cycles. Discard any solution that looks cloudy or contains particles.

DSIP may influence sleep architecture, and combining it with alcohol, benzodiazepines, opioids, or prescription sedatives could compound sedation. Anyone who is pregnant, managing a diagnosed sleep disorder, or taking prescription medication should speak with a healthcare professional before considering it.

No long-term human safety data exists for DSIP, which is the single most important limitation of any dosage figure you find online.

How DSIP Compares With Other Research Peptides

DSIP is one of several peptides sold in 5 mg vials that share nearly identical reconstitution math. Researchers comparing sleep-focused and metabolic-focused compounds often look at aod-9604 5mg dosage alongside DSIP, since both arrive in the same vial size and both are measured in micrograms.

PeptideTypical vial sizeCommonly cited community rangePrimary research focus
DSIP5 mg100–300 mcg, eveningSleep architecture
AOD-96045 mg250–300 mcg dailyFat metabolism
BPC-1575 mg250–500 mcg dailyTissue repair in animal models
TB-5005 mg2–2.5 mg twice weeklyRecovery in animal models

Those figures reflect research and anecdotal use, not approved clinical dosing. Anyone comparing premixed intranasal products should note that people who search buy dsip nasal spray are often purchasing formulations with unclear concentration accuracy and sterility, which adds risk beyond the peptide itself.

Frequently Asked Questions

What is a typical DSIP 5mg dosage?

There is no validated human dosage for DSIP. A 5 mg vial is a quantity of peptide, not a dose, and community and research references most often cite 100 mcg to 300 mcg per administration, usually in the evening. DSIP is not FDA-approved for human use in the United States.

How much bacteriostatic water should I add to a 5 mg DSIP vial?

Adding 2 mL creates a concentration of 2,500 mcg/mL, so 0.1 mL (10 units on a U-100 syringe) equals 250 mcg. Adding 1 mL creates 5,000 mcg/mL, which doubles the strength of every unit but makes small draws harder to measure accurately. Most people choose 2 mL or 3 mL as a practical middle ground.

Is DSIP legal or approved for human use in the US?

DSIP is not FDA-approved for human use and cannot be legally prescribed by a US clinician. It is sold online as a research chemical labeled "for research purposes only," and purity varies between vendors. Anyone considering it should consult a healthcare professional first.

Research information notice

This page provides educational research information and does not replace medical advice, diagnosis, or treatment.